Skip to main content
Công ty Cổ phần Dược phẩm Bến Tre logo

Công ty Cổ phần Dược phẩm Bến Tre — Investor Relations & Filings

Ticker · DBT ISIN · VN000000DBT6 HSX Manufacturing
Filings indexed 422 across all filing types
Latest filing 2026-06-03 Director's Dealing
Country VN Viet Nam
Listing HSX DBT

About Công ty Cổ phần Dược phẩm Bến Tre

www.bepharco.com

Bepharco (Công ty Cổ phần Dược phẩm Bến Tre) is a pharmaceutical company established in 1963, with over 60 years of experience in the production and distribution of pharmaceutical products. The company specializes in a diverse range of offerings, including prescription drugs, health protection foods, and medical equipment. Key product areas include cardiovascular, digestive, and anti-allergy medications, as well as traditional medicine. Bepharco maintains an extensive distribution network across numerous provinces and cities, and exports its products globally. It is recognized for its commitment to quality and its strategic collaborations in pharmaceutical education and research.

Recent filings

Filing Released Lang Actions
DBT: Báo cáo kết quả giao dịch cổ phiếu của tổ chức CLQ đến người nội bộ CTCP An Khang Invest
Director's Dealing Classification · 95% confidence The document is a formal report disclosing the number of shares purchased by an internal person (a board member/CEO) and related parties. It details insider share transactions (dates, quantities, pre- and post-trade holdings) and is addressed to the securities regulator and stock exchange. This matches the definition of Director’s Dealing (insider trading by directors/executives).
2026-06-03 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của tổ chức có liên quan đến người nội bộ CTCP Thương mại và Rang xay Cà phê Việt Nam
Director's Dealing Classification · 95% confidence The document is a detailed report on the sale of shares by an internal person (a member of the Board and CEO) and his affiliated organization. It lists the pre‐ and post‐transaction holdings, number of shares sold, transaction method, date, and related internal person information. This matches an insider/share transaction report by a director/executive. Therefore, it is a Director’s Dealing filing (insider transaction report).
2026-06-03 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của tổ chức có liên quan đến người nội bộ CTCP Thái Dương Investment
Director's Dealing Classification · 95% confidence The document is a mandatory disclosure report submitted to the State Securities Commission and stock exchange detailing the insider (a board member) purchasing shares of the public company. It enumerates pre- and post-transaction share holdings, transaction type, quantity, price, dates, and insider affiliation. This fits the definition of Director’s Dealing (insider trades by directors/executives).
2026-06-03 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của người có liên quan đến người nội bộ Nguyễn Thị Hoàng Oanh
Director's Dealing Classification · 93% confidence The document is a mandatory report on the results of share transactions by an internal person and affiliated person (insider selling). It details personal share sale, quantities, dates, and parties involved. This matches the definition of “Director's Dealing (Code: DIRS)” which covers insider trades by company directors or related parties. Therefore it should be classified as DIRS.
2026-06-03 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của người nội bộ Nguyễn Thái Dương
Director's Dealing Classification · 98% confidence The document is titled “Report on results of transaction in shares/fund certificates/covered warrants of internal person and affiliated persons.” It details a board member’s personal share sale transactions (number of shares sold, ownership percentages before/after, transaction date, etc.). This matches an insider share transaction report by a director/executive. Therefore, it should be classified as Director’s Dealing (DIRS).
2026-06-03 Vietnamese
DBT: Báo cáo kết quả giao dịch cổ phiếu của người nội bộ Phạm Thứ Triệu
Director's Dealing Classification · 94% confidence The document is an Appendix XV disclosure by Ben Tre Pharmaceutical JSC reporting a transaction in the company’s shares by an insider (the Board member and CEO). It details the number of shares sold, percentages before and after, trading method, and date—typical of a director’s/insider’s personal share transaction report. This fits the “Director’s Dealing (DIRS)” category.
2026-06-03 Vietnamese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.